PEPROMENE BIO

PeproMene Bio, Inc is a clinical-stage biotech company in Irvine, California. We are committed to developing novel therapies to treat cancers and immune disorders. Our BAFFR CAR-T therapy program is based on a novel antibody targeting the B-cell Activating Factor Receptor (BAFF-R) discovered by Dr. Larry Kwak's team at MD Anderson Cancer Center, Houston, Texas, and City of Hope National Medical Center, Duarte, California... PeproMene Bio's mission is to develop innovative therapies that will improve the lives of patients with cancer and immune disorders. And to bring cutting-edge therapies like BAFF-R CAR-T to market for patients with unmet medical needs.

Also known as: PeproMene Bio, Inc.

Primary location: Irvine United States